Also, in esophageal squamous cell carcinoma, CD8+ CD103+ TRM cells show enhanced proliferation and cytotoxic potential, measured by Ki67 and CD107a staining, compared to tumor-infiltrating CD8+ CD103– cells after anti-PD-1 therapy [110]. This evidence concerns the gene PDCD1 and neoplasm.